Metabolic phenotyping of genetically modified mice: An NMR metabonomic approach

Biochimie

Volumn 91, Issue 8, 2009, Pages 1053-1057

  Rull, Anna ^a   Vinaixa, Maria ^b   Ángel Rodríguez, Miguel ^b   Beltrán, Raúl ^a   Brezmes, Jesús ^b   Cañellas, Nicolau ^b   Correig, Xavier ^b   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

CYP7A1; MCP 1; Metabonomics; Taurine

Indexed keywords

GLUCOSE; MONOCYTE CHEMOTACTIC PROTEIN 1; TAURINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; MALE; METABOLOMICS; MOUSE; NONHUMAN; PHENOTYPE; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TRANSGENIC ANIMAL;

MUS;

ANIMALS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MICE; MICE, TRANSGENIC; MOLECULAR WEIGHT; PHENOTYPE; WATER;

EID: 67649424750     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.04.019     Document Type: Article

References (11)

1. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., and Rollins B.J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2 (1998) 275-281
2. Tous M., Ferre N., Rull A., Marsillach J., Coll B., Alonso-Villaverde C., Camps J., and Joven J. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem. Biophys. Res. Commun. 340 (2006) 1078-1084
3. Sartipy P., and Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7265-7270
4. Rull A., Escola-Gil J.C., Julve J., Rotllan N., Calpe-Berdiel L., Coll B., Aragones G., Marsillach J., Alonso-Villaverde C., Camps J., Blanco-Vaca F., and Joven J. Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism. Exp. Mol. Pathol. 83 (2007) 361-366
5. Joven J., Rull A., Ferré N., Escolà-Gil J.C., Marsillach J., Coll B., Alonso-Villaverde C., Aragones G., Claria J., and Camps J. The results in rodent models of atherosclerosis are not interchangeable: the influence of diet and strain. Atherosclerosis 195 (2007) e85-e92
6. Tsuboyama-Kasaoka N., Shozawa C., Sano K., Kamei Y., Kasaoka S., Hosokawa Y., and Ezaki O. Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 147 (2006) 3276-3284
7. Murakami S., Kondo-Ohta Y., and Tomisawa K. Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci. 64 (1999) 83-91
8. Elvevoll E.O., Eilertsen K.E., Brox J., Dragnes B.T., Falkenberg P., Olsen J.O., Kirkhus B., Lamglait A., and Osterud B. Seafood diets: hypolipidemic and antiatherogenic effects of taurine and n-3 fatty acids. Atherosclerosis 200 (2008) 396-402
9. Warskulat U., Zhang F., and Häussinger D. Taurine is an osmolyte in rat liver macrophages (Kupffer cells). J. Hepatol. 26 (1997) 1340-1347
10. Warskulat U., Borsch E., Reinehr R., Heller-Stilb B., Mo¡önnighoff I., Buchczyk D., Donner M., Flögel U., Kappert G., Soboll S., Beer S., Pfeffer K., Marschall H., Gabrielsen M., Amiry-Moghaddam M., Ottersen O.P., Dienes H.P., and Häussinger D. Chronic liver disease is triggered by taurine transporter knockout in the mouse. FASEB 20 (2006) 574-576
11. Yokogoshi H., Mochizuki H., Nanami K., Hida Y., Miyachi F., and Oda H. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J. Nutr. 129 (1999) 1705-1712